We can pressure-test the biology, optimize the format, qualify the controls, and build a screening workflow that scales cleanly.
Every productive screening campaign starts with an optimized, validated assay. Our assay development scientists work iteratively with your team to design fit-for-purpose assay formats that balance biological relevance with screening practicality.
Regulatory awareness means every assay we deploy for IND-relevant programs is validated to NCATS or equivalent standards — including reproducibility, specificity, selectivity, and counter-screen alignment.
Our 1536-well automated HTS facility is configured for rapid execution of large-compound-set campaigns with integrated QC, outlier flagging, and automated data analysis delivering clean, publication-quality dose-response datasets.
Moving from a primary screen hit list to a confident, tractable lead series requires rigorous secondary assay confirmation, false positive elimination, and structure-activity triage — all delivered on timelines that maintain program momentum.
Bring us the program question, constraints, and next decision point. We will map the right assays, controls, timeline, and reporting package before the first plate is run.
